Systematic literature review (SLR) and network meta-analysis (NMA) of first-line therapies (1L) for locally advanced/metastatic urothelial carcinoma (la/mUC).

被引：1
|
作者：
Bloudek, Lisa [1 ]
Hepp, Zsolt [1 ]
Mckay, Caroline [1 ]
Derleth, Christina Louise [1 ]
Lill, Jennifer Susan [1 ]
Lenero, Enrique [1 ]
Wright, Phoebe [1 ]
Ramsey, Scott David [1 ]
Sullivan, Sean D. [1 ]
Devine, Beth [1 ]
机构：
[1] Curta Inc, Seattle, WA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 06期
关键词：
D O I：
10.1200/JCO.2022.40.6_suppl.570
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
570
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Systematic Literature Review (SLR) and Network Meta-Analysis (NMA) of First-Line Therapies (1L) for Locally Advanced/Metastatic Urothelial Carcinoma (la/mUC)
    Bloudek, Lisa
    Wright, Phoebe
    McKay, Caroline
    Derleth, Christina Louise
    Lill, Jennifer Susan
    Lenero, Enrique
    Hepp, Zsolt
    Ramsey, Scott David
    Sullivan, Sean D.
    Devine, Beth
    CURRENT ONCOLOGY, 2023, 30 (04) : 3637 - 3647
  • [2] Systematic literature review (SLR) and network meta-analysis (NMA) of first-line (1L) therapies for locally advanced/metastatic urothelial carcinoma (la/mUC)
    Bloudek, L.
    Hepp, Z.
    Mckay, C.
    Devine, B.
    Derleth, C.
    Lill, J.
    Lenero, E.
    Wright, P.
    Ramsey, S. D.
    Sullivan, S. D.
    ANNALS OF ONCOLOGY, 2021, 32 : S715 - S715
  • [3] Systematic literature review and network meta-analysis of first-line therapies for locally advanced/metastatic urothelial carcinoma
    Bloudek, Lisa
    Huang, Shirley
    Wright, Phoebe
    Shih, Vanessa
    Dillon, Ryan
    Martirosyan, Anna
    Pandey, Rajshree
    Williams, Troy
    Chang, Nancy N.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] COST-EFFECTIVENESS (CE) ANALYSES FOR FIRST-LINE (1L) TREATMENT OF ADVANCED OR METASTATIC UROTHELIAL CARCINOMA (MUC): A SYSTEMATIC LITERATURE REVIEW (SLR)
    Braun, N.
    Auti, P.
    Arca, E.
    Teitsson, S.
    Broughton, E.
    May, J. R.
    Kurt, M.
    Alleman, C.
    VALUE IN HEALTH, 2022, 25 (01) : S44 - S44
  • [5] Cost-effectiveness analysis of contemporary first-line (1L) agents in locally advanced/metastatic urothelial carcinoma (la/mUC)
    Naqvi, Syed Arsalan Ahmed
    Faisal, Kunwer Sufyan
    Raina, Ammad
    Khakwani, Kaneez Zahra Rubab
    Bin Riaz, Zaryab
    Shah, Vishal S.
    Cobran, Ewan Kemar
    Singh, Parminder
    Hussain, Syed A.
    Bryce, Alan Haruo
    Bin Riaz, Irbaz
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] First-line (1L) systemic therapy in locally advanced/metastatic urothelial cancer (Ia/mUC): A living interactive systematic review and network meta-analysis.
    Saxena, Akshat
    Bin Riaz, Irbaz
    Naqvi, Syed Arsalan Ahmed
    Bibi, Arifa
    Channar, Aneeta
    Tripathi, Nikita
    Khan, Muhammad Ali
    Raina, Ammad
    Khakwani, Kaneez Zahra Rubab
    Childs, Daniel S.
    Bryce, Alan Haruo
    Singh, Parminder
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] A SYSTEMATIC LITERATURE REVIEW (SLR) TO SUPPORT NETWORK META-ANALYSES (NMA) IN THE TREATMENT OF LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA (LA/MUC) FOLLOWING PD-1/L1 INHIBITORS
    Shah, S. N.
    Wissinger, E.
    Ballew, N.
    Hepp, Z.
    VALUE IN HEALTH, 2019, 22 : S443 - S443
  • [8] Patient-reported outcome (PRO) assessment and reporting in first-line (1L) locally advanced or metastatic urothelial cancer (la/mUC) clinical trials: Results of a systematic literature review (SLR).
    Kearney, Mairead
    Macmillan, Tom
    Poritz, Julia
    Schreiber-Gosche, Sherrie
    Musat, Mihaela Georgiana
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [9] HEALTHCARE RESOURCE UTILIZATION (HCRU) AND COST STUDIES IN PATIENTS RECEIVING FIRST-LINE (1L) THERAPY FOR ADVANCED OR METASTATIC UROTHELIAL CARCINOMA (MUC): A SYSTEMATIC LITERATURE REVIEW (SLR)
    Auti, P.
    Braun, N.
    Arca, E.
    Teitsson, S.
    Broughton, E.
    May, J. R.
    Kurt, M.
    Alleman, C.
    VALUE IN HEALTH, 2022, 25 (01) : S70 - S70
  • [10] Real-world safety of first-line (1L) therapies for locally advanced or metastatic urothelial cancer (la/mUC) in the US.
    Nizam, Amanda
    Kearney, Mairead
    Morris, Valerie A.
    Mahmoudpour, Seyed Hamidreza
    Lobo, Carroline
    Hoffman, Jason
    Iliev, Ilian
    Yerram, Prakirthi
    Guinter, Mark
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
12345